These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 17258836
1. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats. Sharma G, Italia JL, Sonaje K, Tikoo K, Ravi Kumar MN. J Control Release; 2007 Mar 12; 118(1):27-37. PubMed ID: 17258836 [Abstract] [Full Text] [Related]
6. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN. J Control Release; 2007 May 14; 119(1):77-85. PubMed ID: 17349712 [Abstract] [Full Text] [Related]
8. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Arulmozhi V, Pandian K, Mirunalini S. Colloids Surf B Biointerfaces; 2013 Oct 01; 110():313-20. PubMed ID: 23732810 [Abstract] [Full Text] [Related]
9. Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin. Kashyap N, Viswanad B, Sharma G, Bhardwaj V, Ramarao P, Ravi Kumar MN. Biomaterials; 2007 Apr 01; 28(11):2051-60. PubMed ID: 17240443 [Abstract] [Full Text] [Related]
13. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Yilgor P, Tuzlakoglu K, Reis RL, Hasirci N, Hasirci V. Biomaterials; 2009 Jul 01; 30(21):3551-9. PubMed ID: 19361857 [Abstract] [Full Text] [Related]
15. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles. Chung TW, Wang SS, Tsai WJ. Biomaterials; 2008 Jan 01; 29(2):228-37. PubMed ID: 17953984 [Abstract] [Full Text] [Related]
16. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. J Control Release; 2009 Jan 05; 133(1):11-7. PubMed ID: 18950666 [Abstract] [Full Text] [Related]
17. Enhanced oral bioavailability and antioxidant profile of ellagic acid by phospholipids. Murugan V, Mukherjee K, Maiti K, Mukherjee PK. J Agric Food Chem; 2009 Jun 10; 57(11):4559-65. PubMed ID: 19449806 [Abstract] [Full Text] [Related]
18. Effects of ellagic acid by oral administration on distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats. Ho CC, Lai YS, Wang DY, Chen YS, Lee JH, Tang NI, Chung JG. In Vivo; 2005 Jun 10; 19(1):143-56. PubMed ID: 15796167 [Abstract] [Full Text] [Related]
19. Nanoparticles incorporated in bilaminated films: a smart drug delivery system for oral formulations. Cui F, He C, Yin L, Qian F, He M, Tang C, Yin C. Biomacromolecules; 2007 Sep 10; 8(9):2845-50. PubMed ID: 17665945 [Abstract] [Full Text] [Related]
20. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. Sahana DK, Mittal G, Bhardwaj V, Kumar MN. J Pharm Sci; 2008 Apr 10; 97(4):1530-42. PubMed ID: 17722098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]